Active specific immunotherapy with hapten-modified autologous melanoma cell vaccine
β Scribed by Takami Sato
- Book ID
- 105968157
- Publisher
- Springer-Verlag
- Year
- 1996
- Tongue
- English
- Weight
- 243 KB
- Volume
- 43
- Category
- Article
- ISSN
- 0340-7004
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## BACKGROUND. This study was conducted to document the rate, duration, and type of objective response to active specific immunotherapy with a polyvalent melanoma cell vaccine (PMCV) for patients with in-transit melanoma metastases and to identify any acute or chronic toxic effects of PMCV treatme
Although a randomized clinical trial has yet to show a statistically significant improvement in the survival of patients receiving vaccine therapy for malignant melanoma, several studies have shown enhanced survival of patients developing an immune response to a melanoma vaccine. The knowledge and t